Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Syqe inhaled medical cannabis for painful diabetic peripheral neuropathy
MOH_2024-10-30_013481Phase 2Recruiting
- Sponsor
- Syqe Medical
- Start
- Oct 2024
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Cannabis sativa L. 'Afina' in diabetic polyneuropathy (DPN) (4 arms), sponsored by Syqe Medical. Started Oct 2024; status: recruiting.
02
Drugs
Cannabis sativa L. 'Afina'
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on MOH_2024-10-30_013481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2024-10-30_013481.